Quick Listen: The Story Behind The Pharmaprojects’ Pharma R&D Annual Review 2021
In this one-off podcast, hear in the inside story of how the Pharmaprojects’ Pharma R&D Annual Review 2021 is put together, its history and the trends it has revealed in R&D over the years.
You may also be interested in...
INFOGRAPHIC: A snapshot of the industry in key performance indicators surrounding R&D taken in early 2021.
A new analysis reveals the impact of the coronavirus pandemic on pharma R&D in 2020 in two quarters: the total size of the pipeline and in the number of novel products launched in their first markets.
The number of novel products launched in their first markets in 2020 hit record heights in spite of – and in part buoyed by – the pandemic, with an exceptional year for infectious diseases therapeutics and vaccines.